Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute discusses whether or not patients on targeted therapies, such as EGFR inhibitors, should stay on...
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute discusses whether or not patients on targeted therapies, such as EGFR inhibitors, should stay on...
Dr. Charles Rudin of Memorial Sloan Kettering on the possibility of using vaccines to fight lung cancer. February 2014. [powerpress]
Dr. Charles Rudin of Memorial Sloan Kettering on the possibility of using vaccines to fight lung cancer. February 2014. [powerpress]
Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February...
First post and recently joined Grace. Located in Ontario, Canada. I am the caregiver for my wife. She is 54 and on Jan 15th 2017 she collapsed at home...
I was wondering if there is a pathology report chart that can indicate stages of mucosal melanoma with (dermal) mitotic rates?
Is it typical for an oncologist to withhold information until they have the whole picture? What is the typical prognosis for SRCC pancreatic cancer...
My elderly mother with underlying peripheral neuropathy with stage 3 b, egfr positive adeno ca is on her 6 th cycle of reduced dose pemetrexed after...
I am currently a medical student with a passion for Hematology/Oncology. An individual close to me asked if I would take a look at his blood work from...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.